Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 1) 2020
I, Renaye Lucchese, delegate of the Minister for Health, make the following Determination.
Dated 23 March 2020
Renaye Lucchese
Acting Assistant Secretary
Diagnostic Imaging and Pathology Branch
Medical Benefits Division
Health Financing Group
Department of Health
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1— Amendments
Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018
This instrument is the Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment Determination (No. 1) 2020
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 April 2020 |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Health Insurance (Section 3C Co-Dependent Pathology Services) Determination 2018
1 Schedule 1 (item 73336, column 2)
Omit “dabrafenib or vemurafenib”, substitute “dabrafenib, vemurafenib or encorafenib”